2022 annual financial data
Seres Therapeutics 2022 Net margin
Direct answer
Net margin was -3,509.5%.
Operating income was -179,914,000 USD and net income was -250,157,000 USD.
Operating cash flow was -228,816,000 USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,128,000 USD
- Operating income
- -179,914,000 USD
- Net income
- -250,157,000 USD
- Operating cash flow
- -228,816,000 USD